Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NBIX - Neurocrine Biosciences, Inc.


IEX Last Trade
127.06
-1.370   -1.078%

Share volume: 1,236,878
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$128.43
-1.37
-1.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30
Fiscal Quarter Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024
Report Date 2022-11-01 2023-02-09 2023-05-03 2023-08-01 2023-10-31 2024-02-09 2024-05-01 2024-08-01
Total revenue 387.900 M 412.000 M 420.400 M 452.700 M 498.800 M 515.200 M 515.300 M 590.200 M
Cost of revenue 6.100 M 7.700 M 8.500 M 11.500 M 11.200 M 8.500 M 7.500 M 9.200 M
Gross profit 381.800 M 404.300 M 411.900 M 441.200 M 487.600 M 506.700 M 507.800 M 581.000 M
    5.89% 1.88% 7.11% 10.52% 3.92% 0.22% 14.42%  
Operating expenses 294.000 M 300.900 M 382.200 M 367.600 M 346.400 M 356.400 M 402.500 M 433.100 M
Selling general and admin 186.300 M 182.900 M 242.700 M 221.800 M 204.200 M 218.900 M 243.100 M 242.000 M
Research and development 107.700 M 118.000 M 139.500 M 145.800 M 142.200 M 137.500 M 159.400 M 191.100 M
Total expenses 300.100 M 308.600 M 390.700 M 379.100 M 357.600 M 364.900 M 410.000 M 442.300 M
    2.83% 26.60% -2.97% -5.67% 2.04% 12.36% 7.88%  
Operating income 87.800 M 103.400 M 29.700 M 73.600 M 141.200 M 150.300 M 105.300 M 147.900 M
Ebit 87.800 M 103.400 M 29.700 M 73.600 M 141.200 M 150.300 M 105.300 M 147.900 M
Pretax income 97.900 M 117.900 M -103.300 M 121.600 M 115.600 M 198.200 M 34.500 M 98.600 M
    20.43% -187.62% -217.72% -4.93% 71.45% -82.59% 185.80%  
Income tax 29.400 M 28.900 M -26.700 M 26.100 M 32.500 M 50.500 M -8.900 M 33.600 M
Net income basic 68.500 M 89.000 M -76.600 M 95.500 M 83.100 M 147.700 M 43.400 M 65.000 M
    29.93% -186.07% 224.67% -12.98% 77.74% -70.62% 49.77%  
Net income 68.500 M 89.000 M -76.600 M 95.500 M 83.100 M 147.700 M 43.400 M 65.000 M
    29.93% -186.07% 224.67% -12.98% 77.74% -70.62% 49.77%